Cargando…

Extracellular volume fraction is associated with B-type natriuretic peptide in hypertrophic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Wong, Timothy C, Chung, Jeffrey, Kellman, Peter, Schelbert, Erik B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042607/ http://dx.doi.org/10.1186/1532-429X-16-S1-P331

Ejemplares similares

Pulmonary artery pressure is associated with extracellular volume fraction in patients with normal left ventricular function
por: Cater, George M, et al.
Publicado: (2016)

Myocardial fibrosis quantified by the extracellular extravascular volume fraction is associated with the left ventricular sphericity index and the left atrial volume index
por: Moguillansky, Diego, et al.
Publicado: (2012)

Extracellular volume fraction measured by MOLLI: slow infusion versus bolus
por: Schelbert, Erik, et al.
Publicado: (2011)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Prevalence of increased myocardial extracellular volume fraction in dilated cardiomyopathy
por: Lundin, Magnus, et al.
Publicado: (2013)

Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
por: Sado, Daniel, et al.
Publicado: (2013)

The clinical and CMR Characteristics of Hypertrophic Cardiomyopathy with Restrictive Phenotype
por: Lu, Minjie, et al.
Publicado: (2016)

In vivo diffusion-weighted MRI detection of myocardial fibrosis in hypertrophic cardiomyopathy patients
por: Nguyen, Christopher T, et al.
Publicado: (2015)

Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodelling
por: Lu, Minjie, et al.
Publicado: (2016)

Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy
por: Fries, Ryan C., et al.
Publicado: (2021)

Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects
por: Im, Dong Jin, et al.
Publicado: (2015)

In patients with acute myocarditis, the difference in apparent extracellular volume fraction between affected and healthy myocardium does not differ between early and late post-contrast imaging
por: Lundin, Magnus, et al.
Publicado: (2016)

Extravascular lung water, B-type natriuretic peptide and blood volume contraction for diagnosing weaning-induced pulmonary edema
por: Dres, M, et al.
Publicado: (2013)

A novel natriuretic peptide
por: Höfeld, Hanna, et al.
Publicado: (2011)

Significance of B-type natriuretic peptide in acute cerebrovascular disease
por: Stevens, R, et al.
Publicado: (2006)

Sex Differences in Time-Dependent Changes in B-Type Natriuretic Peptide in Hypertrophic Cardiomyopathy
por: Enzan, Nobuyuki, et al.
Publicado: (2021)

Sample size calculation for clinical trials using cardiac magnetic resonance partition coefficient and extracellular volume fraction for the assessment of diffuse myocardial fibrosis
por: Liu, Songtao, et al.
Publicado: (2013)

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

Plasma free cortisol and b-type natriuretic peptide in septic shock
por: Sturgess, D, et al.
Publicado: (2011)

Extracellular volume fractions are not consistent in gray zones determined by late gadolinium enhancement imaging of myocardial infarction
por: Parikh, Paras, et al.
Publicado: (2016)

CMR assessment of hypertrophic cardiomyopathy with restrictive phenotype
por: Lu, Minjie, et al.
Publicado: (2015)

Elevated myocardial extracellular volume fraction in Duchenne muscular dystrophy
por: Starc, James, et al.
Publicado: (2016)

Quantitative assessment of myocardial extracellular volume fraction in non-ischemic dilated cardiomyopathy and its relation to systolic dysfunction
por: Ali, Aamir, et al.
Publicado: (2013)

Comparison of global extracellular volume (ECV) and late gadolinium enhancement (LGE) to predict the estimated 5 year risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM)
por: Avanesov, Maxim, et al.
Publicado: (2016)

B-type natriuretic peptide single nucleotide polymorphism rs198389 and survival in the general community
por: Boerrigter, Guido, et al.
Publicado: (2009)

Pro-B-type natriuretic peptide predicts mortality in critically ill patients
por: Meyer, B, et al.
Publicado: (2005)

Quantitative of myocardial extracellular volume fraction improves characterization of fibrotic burden in patients with apical hypertrophic cardiomyopathy beyond visual assessment with late gadolinium enhancement
por: Watanabe, Eri, et al.
Publicado: (2012)

Gene database for the development of genetic testing for hypertrophic cardiomyopathy
por: Silas, Justin Carlus, et al.
Publicado: (2014)

Non-contrast T1rho CMR for hypertrophic cardiomyopathy
por: Wang, Chunhua, et al.
Publicado: (2015)

Left atrial remodeling and mechanical dysfunction in hypertrophic cardiomyopathy
por: Kim, Kyung-Jin, et al.
Publicado: (2016)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

Characterization of dilated cardiomyopathy using tissue phase mapping and extracellular volume measurement
por: Sommerville, Lewis C, et al.
Publicado: (2013)

Prognostic value of amino terminal pro-b-type natriuretic peptide in septic patients
por: Maroto, Fernando, et al.
Publicado: (2008)

Sepsis-associated diastolic dysfunction without elevated plasma B-type natriuretic peptide
por: Sturgess, DJ, et al.
Publicado: (2008)

Extracellular volume MRI increases the detection of myocardial abnormalities beyond late gadolinium enhancement - initial findings
por: Lundin, Magnus, et al.
Publicado: (2012)

Manipulating the natriuretic peptide system for the treatment of pulmonary hypertension
por: Baliga, Reshma S, et al.
Publicado: (2009)

Genotype positive hypertrophic cardiomyopathy is associated with myocardial perfusion abnormalities
por: Keenan, Niall G, et al.
Publicado: (2014)

Native T1 is predictive of abnormal myocardial strain in hypertrophic cardiomyopathy
por: Jensen, Patrick J, et al.
Publicado: (2015)

A subset of hypertrophic cardiomyopathy patients is predisposed to angulated septum
por: Liu, Rebecca, et al.
Publicado: (2015)

Extracellular volume fraction mapping at 3T with non-rigid image co-registration
por: Le, Thu Thao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f7nmd3dus779jp2gh15826tpta